Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Localized scleroderma--response to 1,25-dihydroxyvitamin D3.

P G Humbert¹, J L Dupond, A Rochefort

¹Department of Dermatology, Centre Hospitalier Universitaire St-Jacques, Besançon, France.

Clinical and Experimental Dermatology

|September 1, 1990

Summary

This study suggests that 1,25-dihydroxyvitamin D3 (1,25(OH)2 D3) may effectively treat localized scleroderma. The hormone showed benefits in a patient by improving skin condition over six months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Complex regulation of LCoR signaling in breast cancer cells.

Oncogene·2017

Same author

Patient-Specific Finite-Element Simulation of the Insertion of Guidewire During an EVAR Procedure: Guidewire Position Prediction Validation on 28 Cases.

IEEE transactions on bio-medical engineering·2016

Same author

A versatile intensity-based 3D/2D rigid registration compatible with mobile C-arm for endovascular treatment of abdominal aortic aneurysm.

International journal of computer assisted radiology and surgery·2016

Same author

Predictors of expressed breast milk volume in mothers expressing milk for their preterm infant.

Archives of disease in childhood. Fetal and neonatal edition·2016

Same author

Estimation of clinically relevant indicators for EVAR using patient-specific finite element simulation.

Computer methods in biomechanics and biomedical engineering·2015

Same author

Safety and accuracy of endovascular aneurysm repair without pre-operative and intra-operative contrast agent.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015

Area of Science:

Endocrinology
Dermatology
Immunology

Background:

1,25-dihydroxyvitamin D3 (1,25(OH)2 D3) exhibits potential immunomodulatory properties.
It may influence collagen deposition and fibrosis reversal.
These characteristics suggest a possible therapeutic role in fibrotic skin conditions like scleroderma.

Purpose of the Study:

To investigate the efficacy of 1,25(OH)2 D3 in treating localized scleroderma.
To evaluate the effects of oral 1,25(OH)2 D3 on skin parameters in a scleroderma patient.

Main Methods:

A case study involving a 35-year-old woman with localized scleroderma.
Administration of oral 1,25(OH)2 D3 for a duration of six months.
Assessment of treatment effects through clinical and physical measurements, including skin thickness and extensibility.

Related Experiment Videos

Main Results:

The patient's condition showed improvement during the six-month treatment period.
Clinical and physical measurements indicated beneficial effects of 1,25(OH)2 D3 therapy.
The observed improvements suggest a positive response to the hormone treatment.

Conclusions:

Oral 1,25(OH)2 D3 appears to be beneficial for localized scleroderma.
Potential mechanisms include immunoregulatory effects and inhibition of fibroblast growth.
Further research is warranted to confirm these findings and explore therapeutic applications.